{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:40:00Z","timestamp":1790354400600,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioPsychoSocial Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Some patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complain of persistent fatigue, dyspnea, pain, and cognitive dysfunction. These symptoms are often described as \u201clong COVID\u201d. Whether a patient with long COVID might develop myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is of interest, as is the treatment and management of ME\/CFS in a post-COVID patient. Here I report a patient, who, after an infection with SARS-CoV-2, developed ME\/CFS and recovered after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a previously healthy 55-year-old woman who worked as a nurse and became ill with COVID-19 pneumonia. She then presented with severe fatigue, post-exertional malaise, dyspnea, pain, cognitive dysfunction, tachycardia, and exacerbation of fatigue on physical exertion, which persisted for more than 6\u00a0months after her recovery from COVID-19 pneumonia. She was bedridden for more than half of each day. The patient was treated from multiple perspectives, which included (1) instructions on eating habits and supplements; (2) cognitive and behavioral modifications for coping with physical, emotional, and cognitive fatigue; (3) instructions on conditioning exercises to improve deconditioning due to fatigue and dyspnea; and (4) pharmacotherapy with amitriptyline and <jats:italic>hochuekkito<\/jats:italic>, a Japanese herbal (<jats:italic>Kampo<\/jats:italic>) medicine. The patient made a complete recovery after completing the prescribed regimen and was able to return to work as a nurse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To the best of my knowledge, this is the first detailed report on a patient infected with SARS-CoV-2 followed by long COVID with the signs\/symptoms of ME\/CFS who recovered after treatment. I hope this case report will be helpful to health care practitioners by its presentation of some of the therapeutic options for alleviating disabling signs\/symptoms in patients with post-COVID ME\/CFS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13030-022-00260-3","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:28:59Z","timestamp":1677756539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A patient who recovered from post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Takakazu","family":"Oka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"6","key":"260_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carfi","year":"2020","unstructured":"Carfi A, Bernabei R, Landi F. Gemelli Against C-P-ACSG: persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603\u20135.","journal-title":"JAMA"},{"issue":"6","key":"260_CR2","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","volume":"81","author":"E Garrigues","year":"2020","unstructured":"Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4\u20136.","journal-title":"J Infect"},{"issue":"9","key":"260_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428\u201342.","journal-title":"J R Soc Med"},{"key":"260_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374: n1648.","journal-title":"BMJ"},{"issue":"12","key":"260_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study international chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953\u20139.","journal-title":"Ann Intern Med"},{"key":"260_CR6","doi-asserted-by":"publisher","unstructured":"Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles P, Sherkey JA, van de Sande MI. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J Chron Fatigue Synd. 2003;11(1):7-115. https:\/\/doi.org\/10.1300\/J092v11n01_02.","DOI":"10.1300\/J092v11n01_02"},{"issue":"22","key":"260_CR7","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH Lam","year":"2009","unstructured":"Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, So WY, Fong SY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142\u20137.","journal-title":"Arch Intern Med"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.","journal-title":"BMC Neurol"},{"key":"260_CR9","first-page":"204993612110093","volume":"8","author":"S Poenaru","year":"2021","unstructured":"Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009384.","journal-title":"Ther Adv Infect Dis"},{"key":"260_CR10","unstructured":"Carruthers BM, van de Sande MI. Myalgic encephalomyelitis\/chronic fatigue syndrome: a clinical case definition and guidelines for medical practitioners - An Overview of the Canadian Consensus Document 2005. (ISBN: 0-9739335-0-X). http:\/\/www.investinme.org\/Documents\/PDFdocuments\/Canadian_ME_Overview_A4.pdf. Accessed 10 July 2022."},{"issue":"2","key":"260_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0885-3924(02)00596-1","volume":"25","author":"T Okuyama","year":"2003","unstructured":"Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003;25(2):106\u201317.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"260_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1037\/1040-3590.7.2.220","volume":"7","author":"JA Arnett","year":"1995","unstructured":"Arnett JA, Labovitz SS. Effect of physical layout in performance of the Trail Making Test. Psychol Assess. 1995;7(2):220\u20131.","journal-title":"Psychol Assess"},{"key":"260_CR13","unstructured":"Japan Society for Higher Brain Dysfunction. BFTC: TMT-J. Tokyo (Japan): Shinkoh-Igaku Shuppansha; 2019."},{"issue":"1","key":"260_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1751-0759-7-7","volume":"7","author":"T Oka","year":"2013","unstructured":"Oka T, Kanemitsu Y, Sudo N, Hayashi H, Oka K. Psychological stress contributed to the development of low-grade fever in a patient with chronic fatigue syndrome: a case report. Biopsychosoc Med. 2013;7(1):7.","journal-title":"Biopsychosoc Med"},{"issue":"1","key":"260_CR15","first-page":"12","volume":"35","author":"T Oka","year":"2015","unstructured":"Oka T. Efficacy and limitations of autogenic training as a treatment of chronic fatigue syndrome. Jpn J Autogenic Ther. 2015;35(1):12\u20139.","journal-title":"Jpn J Autogenic Ther"},{"issue":"2","key":"260_CR16","first-page":"16","volume":"14","author":"T Oka","year":"2019","unstructured":"Oka T. Usefulness of a \u201cfever-fatigue diary\u201d and \u201cenergy savings passbook\u201d in treating patients with ME\/CFS. J Fatigue Sci. 2019;14(2):16\u201322.","journal-title":"J Fatigue Sci"},{"issue":"4","key":"260_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/nu13041154","volume":"13","author":"C Vollbracht","year":"2021","unstructured":"Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13(4):1154.","journal-title":"Nutrients"},{"key":"260_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biopsycho.2016.05.005","volume":"118","author":"S Fukuda","year":"2016","unstructured":"Fukuda S, Nojima J, Motoki Y, Yamaguti K, Nakatomi Y, Okawa N, Fujiwara K, Watanabe Y, Kuratsune H. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. 2016;118:88\u201393.","journal-title":"Biol Psychol"},{"issue":"21","key":"260_CR19","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.3390\/jcm10215077","volume":"10","author":"A Varesi","year":"2021","unstructured":"Varesi A, Deumer US, Ananth S, Ricevuti G. The emerging role of gut microbiota in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): current evidence and potential therapeutic applications. J Clin Med. 2021;10(21):5077.","journal-title":"J Clin Med"},{"key":"260_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13030-020-00193-9","volume":"14","author":"T Oka","year":"2020","unstructured":"Oka T. Shitsu-taikan-sho (alexisomia): a historical review and its clinical importance. Biopsychosoc Med. 2020;14:23.","journal-title":"Biopsychosoc Med"},{"issue":"13","key":"260_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa070447","volume":"358","author":"S Levine","year":"2008","unstructured":"Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"260_CR22","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","volume":"21","author":"M Dani","year":"2021","unstructured":"Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in \u201clong COVID\u201d: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63\u20137.","journal-title":"Clin Med (Lond)"},{"key":"260_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijid.2021.11.020","volume":"114","author":"A Dotan","year":"2022","unstructured":"Dotan A, Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis. 2022;114:233\u20135.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"260_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ecam\/nen003","volume":"7","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evid Based Complement Alternat Med. 2010;7(3):367\u201373.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"260_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/tkm2.1264","volume":"8","author":"S Takayama","year":"2021","unstructured":"Takayama S, Kikuchi A, Makino T, Kainuma M, Namiki T, Ito T. Basic pharmacological mechanisms and clinical evidence of the efficacy of Hochuekkito against infectious diseases and its potential for use against COVID-19. Traditional & Kampo Medicine. 2021;8(1):3\u201321.","journal-title":"Traditional & Kampo Medicine"},{"issue":"4","key":"260_CR26","first-page":"468","volume":"42","author":"T Oka","year":"2021","unstructured":"Oka T. Kampo therapy for ME\/CFS in Japan. Clin J Trad Chin Med. 2021;42(4):468\u201373.","journal-title":"Clin J Trad Chin Med"},{"issue":"4","key":"260_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1534735410383170","volume":"9","author":"JS Jeong","year":"2010","unstructured":"Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther. 2010;9(4):331\u20138.","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"260_CR28","first-page":"439","volume":"43","author":"T Oka","year":"1993","unstructured":"Oka T, Komiyama H, Nakagawa T. MAtsuura T, Oka K: Studies on the effects of rikkunshi-to and hochuekki-to on adrenal and autonomic nervous functions. Jpn J Oriental Med. 1993;43(3):439\u201346.","journal-title":"Jpn J Oriental Med"},{"issue":"1","key":"260_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1248\/bpb.b19-00616","volume":"43","author":"Q He","year":"2020","unstructured":"He Q, Sawada M, Yamasaki N, Akazawa S, Furuta H, Uenishi H, Meng X, Nakahashi T, Ishigaki Y, Moriya J. Neuroinflammation, oxidative stress, and neurogenesis in a mouse model of chronic fatigue syndrome, and the treatment with kampo medicine. Biol Pharm Bull. 2020;43(1):110\u20135.","journal-title":"Biol Pharm Bull"}],"container-title":["BioPsychoSocial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13030-022-00260-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13030-022-00260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:29:07Z","timestamp":1677756547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpsmedicine.biomedcentral.com\/articles\/10.1186\/s13030-022-00260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/s13030-022-00260-3","relation":{},"ISSN":["1751-0759"],"issn-type":[{"value":"1751-0759","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Oral informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests in relation to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}